Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma.
Hashmi H, Mirza AS, Darwin A, Logothetis C, Garcia F, Kommalapati A, Mhaskar RS, Bachmeier C, Chavez JC, Shah B, Pinilla-Ibarz J, Khimani F, Lazaryan A, Liu H, Davila ML, Locke FL, Nishihori T, Jain MD. Hashmi H, et al. Among authors: kommalapati a. Blood Adv. 2020 Sep 8;4(17):4086-4090. doi: 10.1182/bloodadvances.2020002060. Blood Adv. 2020. PMID: 32877523 Free PMC article.
Quality of life in caregivers of patients receiving chimeric antigen receptor T-cell therapy.
Barata A, Hoogland AI, Hyland KA, Otto AK, Kommalapati A, Jayani RV, Irizarry-Arroyo N, Collier A, Rodriguez Y, Welniak TL, Booth-Jones M, Logue J, Small BJ, Jain MD, Reblin M, Locke FL, Jim HSL. Barata A, et al. Among authors: kommalapati a. Psychooncology. 2021 Aug;30(8):1294-1301. doi: 10.1002/pon.5674. Epub 2021 Apr 1. Psychooncology. 2021. PMID: 33739548 Free PMC article.
Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy.
Hoogland AI, Barata A, Logue J, Kommalapati A, Hyland KA, Nelson AM, Eisel SL, Small BJ, James BW, Christy SM, Bulls HW, Booth-Jones M, Jayani RV, Jain MD, Mokhtari S, Chavez JC, Lazaryan A, Shah BD, Locke FL, Jim HSL. Hoogland AI, et al. Among authors: kommalapati a. Transplant Cell Ther. 2022 Jun;28(6):305.e1-305.e9. doi: 10.1016/j.jtct.2022.03.023. Epub 2022 Apr 1. Transplant Cell Ther. 2022. PMID: 35378330 Free PMC article.
Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma.
Barata A, Hoogland AI, Kommalapati A, Logue J, Welniak T, Hyland KA, Eisel SL, Small BJ, Jayani RV, Booth-Jones M, Oswald LB, Gonzalez BD, Kirtane KS, Jain MD, Mokhtari S, Chavez JC, Lazaryan A, Shah BD, Locke FL, Jim HSL. Barata A, et al. Among authors: kommalapati a. Transplant Cell Ther. 2022 Jul;28(7):401.e1-401.e7. doi: 10.1016/j.jtct.2022.05.015. Epub 2022 May 14. Transplant Cell Ther. 2022. PMID: 35580732 Free PMC article.
Novel targeted treatment options for advanced cholangiocarcinoma.
Mahipal A, Kommalapati A, Tella SH, Lim A, Kim R. Mahipal A, et al. Among authors: kommalapati a. Expert Opin Investig Drugs. 2018 Sep;27(9):709-720. doi: 10.1080/13543784.2018.1512581. Epub 2018 Aug 30. Expert Opin Investig Drugs. 2018. PMID: 30124336 Review.
61 results